Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Deep mutational scanning of the RBD from SARS-CoV-2 variant lineages using yeast display of barcoded libraries

PROVIDER: PRJNA770094 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16287116.fastq.gz	Fastqsanger.gz
	SRR16287117.fastq.gz	Fastqsanger.gz
	SRR16287118.fastq.gz	Fastqsanger.gz
	SRR16287119.fastq.gz	Fastqsanger.gz
	SRR16287120.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 756

Similar Datasets

Project description:deep mutational scanning of the SARS-CoV-2 RBD using yeast display of barcoded libraries

| PRJNA639956 | ENA

Project description:Deep mutational scanning of SARS-related coronavirus RBDs using yeast display of barcoded libraries

| PRJNA962117 | ENA

Project description:Serum antibody binding to SARS-CoV-2 RBD variant libraries using yeast display

| PRJNA1264489 | ENA

SARS-CoV-2 pseudovirus strain:XBB.1.5

Project description:SARS-CoV-2 XBB.1.5 RBD-only pseudovirus based deep mutational scanning libraries

| PRJNA1035795 | ENA

Germinal center-mediated broadening of B cell responses to SARS-CoV-2 booster immunization

Project description:Germinal centers (GC) are key sites for antibody diversification and affinity maturation. SARS-CoV-2 mRNA vaccines elicit robust GC B cell responses in humans, but how these influence the breadth of immunity against viral variants remains unclear. We analyzed GC B cell responses in nine healthy adults following mRNA booster immunization. We show that 77.8% of the B cell clones in the GC expressed representative monoclonal antibodies (mAbs) recognizing the spike protein, with 37.8% of these targeting the receptor-binding domain (RBD). One RBD-targeting mAb, mAb-52, neutralized all tested SARS-CoV-2 strains, including the recent XEC variant. mAb-52 utilized the IGHV3-66 public clonotype, protected hamsters challenged against the EG.5.1 variant, and targeted the class I/II RBD epitope, closely mimicking the binding footprint of ACE2. Its broad reactivity was driven by extensive somatic hypermutation, underscoring the critical role of GC reactions in shaping cross-variant B cell immunity following SARS-CoV-2 booster vaccination.

2025-09-16 | GSE292810 | GEO

Project description:High-throughput surveys of SARS-related coronavirus RBDs using yeast display of barcoded libraries

| PRJNA714677 | ENA

Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice

Project description:Global containment of COVID-19 still requires accessible and affordable vaccines for low- and middle-income countries (LMICs). Recently approved vaccines provide needed interventions, albeit at prices that may limit their global access. Subunit vaccines based on recombinant proteins are suited for large-volume microbial manufacturing to yield billions of doses annually, minimizing their manufacturing cost. These types of vaccines are well-established, proven interventions with multiple safe and efficacious commercial examples. Many vaccine candidates of this type for SARS-CoV-2 rely on sequences containing the receptor-binding domain (RBD), which mediates viral entry to cells via ACE2. Here we report an engineered sequence variant of RBD that exhibits high-yield manufacturability, high-affinity binding to ACE2, and enhanced immunogenicity after a single dose in mice compared to the Wuhan-Hu-1 variant used in current vaccines. Antibodies raised against the engineered protein exhibited heterotypic binding to the RBD from two recently reported SARS-CoV-2 variants of concern (501Y.V1/V2). Presentation of the engineered RBD on a designed virus-like particle (VLP) also reduced weight loss in hamsters upon viral challenge.

2021-09-09 | GSE172054 | GEO

Project description:High-throughput deep mutational scanning of SARS-CoV-2 RBD neutralizing antibodies for epitope identification and antibody classification with yeast surface display and MACS-based selection. Raw sequence reads

| PRJNA787091 | ENA

Project description:Deep mutational scanning of germline and somatic CR9114 by yeast display and Tite-Seq

| PRJNA1284397 | ENA

Peripheral Blood Mononuclear Cell Electrophysiology as a Marker for Immune Response to Exposure and Vaccination

Project description:Comparison of cell stimulated with SARS-CoV-2 RBD, peptide mix or control. Samples from 3 donors post second vaccine dose.

2025-04-01 | E-MTAB-14606 | biostudies-arrayexpress